TUSTIN, Calif.--(BUSINESS WIRE)--Toshiba America Medical Systems, Inc. today announced the completion of enrollment for 400 patients in its CorE 64 (Coronary Evaluation on 64) study taking place across seven countries, the largest trial ever initiated evaluating the use of 64-slice CT technology. The trial’s enrollment completion signifies that the study of all patient participants has finished, resulting in the most statistically reliable data available to date.
